The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 330:969-973 April 7, 1994 Number 14
NextNext

Prenatal Diagnosis of X-Linked Hyper-IgM Syndrome
James P. DiSanto, Sophie Markiewicz, Jean-Francois Gauchat, Jean-Yves Bonnefoy, Alain Fischer, and Genevieve de Saint Basile

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
The inability to initiate switching from one immunoglobulin isotype to another is the hallmark of the hyper-IgM immunodeficiency syndrome1. Patients with this primary immune disorder, originally termed "dysgammaglobulinemia type 1,"2 usually present with recurrent bacterial infections, including otitis media and pneumonia. Additional clinical features include opportunistic infections, recurrent neutropenia, lymphoid hyperplasia, and autoimmune manifestations. Abnormalities of serum immunoglobulins include low levels or an absence of IgG, IgA, and IgE and normal or, more frequently, elevated levels of IgM and IgD. The hyper-IgM syndrome can be inherited in an X-linked or autosomal recessive fashion.

The candidate gene for this disease . . . [Full Text of this Article]

Methods

Families with the Hyper-IgM Syndrome

Prenatal Analysis

Microsatellite Typing

Mutational Analysis of the CD40 Ligand Gene

Results

CD40 Ligand Microsatellite Repeat

Segregation of the CD40 Ligand CA Repeat in Families with the Hyper-IgM Syndrome

Prenatal Diagnosis of the Hyper-IgM Syndrome

Discussion


Source Information

From INSERM Unite 132, Hopital Necker-Enfants Malades, Paris (J.P.D., S.M., A.F., G.S.B.), and the Glaxo Institute for Molecular Biology, Plan-les-Ouates, Geneva (J.-F.G., J.-Y.B.).

Address reprint requests to Dr. DiSanto at INSERM Unite 132, Hopital Necker-Enfants Malades, 149, rue de Sevres, 75743 Paris CEDEX 15, France.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.